Nonalcoholic fatty liver disease as a comorbidity of childhood obesity

Papers of special note have been highlighted as: • of interest •• of considerable interest

Bibliography

• 1  Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C: Prevalence of fatty liver in children and adolescents. Pediatrics118(4),1388–1393 (2006).•• The best estimate of the prevalence of nonalcoholic fatty liver disease (NAFLD) in the pediatric populationand demonstrates key demographic differences in prevalence using histology for diagnosis.
  MedlineGoogle Scholar
• 2  Schwimmer JB: Chapter 34: Nonalcoholic fatty liver disease. Liver Disease in Children, Third Edition. (34),830–839 (2007).
  Google Scholar
• 3  Bugianesi E, Leone N, Vanni E et al.: Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology123(1),134–140 (2002).
  MedlineGoogle Scholar
• 4  Feldstein AE, Treeprasertsuk S, Charatcharoenwitthyaya P, Benson JT, Enders F, Angulo P: The natural history of nonalcoholic fatty liver disease in children: a follow-up study for up to 20 years. Hepatology48(S1),335A (2008).• First long-term follow-up study of children with NAFLD.
  Google Scholar
• 5  Janssen I, Katzmarzyk PT, Boyce WF et al.: Comparison of overweight and obesity prevalence in school-aged youth from 34 countries and their relationships with physical activity and dietary patterns. Obes. Rev.6(2),123–132 (2005).
  Medline CASGoogle Scholar
• 6  Park HS, Han JH, Choi KM, Kim SM: Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am. J. Clin. Nutr.82(5),1046–1051 (2005).
  Medline CASGoogle Scholar
• 7  Strauss RS, Barlow SE, Dietz WH: Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J. Pediatr.136(6),727–733 (2000).
  Medline CASGoogle Scholar
• 8  Chan DF, Li AM, Chu WC et al.: Hepatic steatosis in obese Chinese children. Int. J. Obes. Relat. Metab. Disord.28(10),1257–1263 (2004).
  Medline CASGoogle Scholar
• 9  Franzese A, Vajro P, Argenziano A et al.: Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig. Dis. Sci.42(7),1428–1432 (1997).
  Medline CASGoogle Scholar
• 10  Tazawa Y, Noguchi H, Nishinomiya F, Takada G: Serum alanine aminotransferase activity in obese children. Acta Paediatr.86(3),238–241 (1997).
  Medline CASGoogle Scholar
• 11  Riley MR, Bass NM, Rosenthal P, Merriman RB: Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists. J. Pediatr.147(6),839–842 (2005).
  MedlineGoogle Scholar
• 12  Manton ND, Lipsett J, Moore DJ, Davidson GP, Bourne AJ, Couper RT: Non-alcoholic steatohepatitis in children and adolescents. Med. J. Aust.173(9),476–479 (2000).
  Medline CASGoogle Scholar
• 13  Rashid M, Roberts EA: Nonalcoholic steatohepatitis in children. J. Pediatr. Gastroenterol. Nutr.30(1),48–53 (2000).
  Medline CASGoogle Scholar
• 14  Manco M, Alisi A, Nobili V: Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report. Hepatology.48(6),2087–2088; author reply 2088 (2008).
  MedlineGoogle Scholar
• 15  Manco M, Bedogni G, Marcellini M et al.: Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut57(9),1283–1287 (2008).
  Medline CASGoogle Scholar
• 16  Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V: Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int. J. Obes. (Lond).32(2),381–387 (2008).
  Medline CASGoogle Scholar
• 17  Patton HM, Lavine JE, Van Natta ML et al.: Clinical correlates of histopathologyin pediatric nonalcoholic steatohepatitis. Gastroenterology135(6),1961–1971 (2008).•• Identifies components of routine laboratory tests that are predictive of NAFLD pattern and severity on liver biopsy in children with NAFLD.
  MedlineGoogle Scholar
• 18  Nobili V, Parkes J, Bottazzo G et al.: Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology (2008).
  Google Scholar
• 19  Weigand K, Weigand K: Percutaneous liver biopsy: retrospective study over 15 years comparing 287 inpatients with 428 outpatients. J. Gastroenterol. Hepatol. (2009) (Epub ahead of print).
  MedlineGoogle Scholar
• 20  Zamcheck N, Klausenstock O: Liver biopsy. II. The risk of needle biopsy. N. Engl. J. Med.249(26),1062–1069; concl (1953).
  Medline CASGoogle Scholar
• 21  Piccinino F, Sagnelli E, Pasquale G, Giusti G: Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J. Hepatol.2(2),165–173 (1986).
  Medline CASGoogle Scholar
• 22  Azzam RK, Alonso EM, Emerick KM,Whitington PF: Safety of percutaneous liver biopsy in infants less than three months old. J. Pediatr. Gastroenterol. Nutr.41(5),639–643 (2005).
  Medline CASGoogle Scholar
• 23  Cohen MB, A-Kader HH, Lambers D, Heubi JE: Complications of percutaneous liver biopsy in children. Gastroenterology.102(2),629–632 (1992).
  Medline CASGoogle Scholar
• 24  Lachaux A, Le Gall C, Chambon M et al.: Complications of percutaneous liver biopsy in infants and children. Eur. J. Pediatr.154(8),621–623 (1995).
  Medline CASGoogle Scholar
• 25  Lichtman S, Guzman C, Moore D, Weber JL, Roberts EA: Morbidity after percutaneous liver biopsy. Arch. Dis. Child.62(9),901–904 (1987).
  Medline CASGoogle Scholar
• 26  Bydder M, Yokoo T, Hamilton Get al.: Relaxation effects in the quantification of fat using gradient echo imaging. Magn. Reson. Imaging26(3),347–359 (2008).
  MedlineGoogle Scholar
• 27  Reeder SB, Ranallo F, Taylor AJ: CT and MRI for determining hepatic fat content. Am. J. Roentgenol.190(2),W167; author reply W168 (2008).
  MedlineGoogle Scholar
• 28  Hussain HK, Chenevert TL, Londy FJ et al.: Hepatic fat fraction: MR imaging for quantitative measurement and display – early experience. Radiology237(3),1048–1055 (2005).
  MedlineGoogle Scholar
• 29  Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB: Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology239(2),425–437 (2006).
  MedlineGoogle Scholar
• 30  Celle G, Savarino V, Picciotto A, Magnolia MR, Scalabrini P, Dodero M: Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques. Dig. Dis. Sci.33(4),467–471 (1988).
  Medline CASGoogle Scholar
• 31  Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A: MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr.96(4),542–547 (2007).• Usng MRI, highlights the limitations of ultrasound for detecting and grading fatty liver in children.
  MedlineGoogle Scholar
• 32  Nobili V, Vizzutti F, Arena U et al.: Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology48(2),442–448 (2008).
  Medline CASGoogle Scholar
• 33  Schwimmer JB, Behling C, Newbury R et al.: Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology42(3),641–649 (2005).•• Defines the two distinct histological patterns of pediatric nonalcoholic steatohepatitis.
  MedlineGoogle Scholar
• 34  Day CP and James OF: Steatohepatitis: a tale of two ‘hits’? Gastroenterology114(4),842–845 (1998).
  Medline CASGoogle Scholar
• 35  Tominaga K, Kurata JH, Chen YK et al.: Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig. Dis. Sci.40(9),2002–2009 (1995).
  Medline CASGoogle Scholar
• 36  Guzzaloni G, Grugni G, Minocci A, Moro D, Morabito F: Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int. J. Obes. Relat. Metab. Disord.24(6),772–776 (2000).
  Medline CASGoogle Scholar
• 37  Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE: Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J. Pediatr.127(5),700–704 (1995).
  Medline CASGoogle Scholar
• 38  Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE: Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J. Pediatr.143(4),500–505 (2003).
  MedlineGoogle Scholar
• 39  Fishbein MH, Mogren C, Gleason T, Stevens WR: Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J. Pediatr. Gastroenterol. Nutr.42(1),83–88 (2006).• Demonstrates that body fat distribution is more important than total body fat in the development of hepatic steatosis.
  MedlineGoogle Scholar
• 40  Nakao K, Nakata K, Ohtsubo N et al.: Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults. Am. J. Gastroenterol.97(7),1796–1801 (2002).
  Medline CASGoogle Scholar
• 41  Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M: The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J. Pediatr. Gastroenterol. Nutr.24(3),317–321 (1997).
  Medline CASGoogle Scholar
• 42  Gill SR, Pop M, Deboy RT et al.: Metagenomic analysis of the human distal gut microbiome. Science312(5778),1355–1359 (2006).
  Medline CASGoogle Scholar
• 43  Turnbaugh PJ, Hamady M, Yatsunenko T et al.: A core gut microbiome in obese and lean twins. Nature457(7228),480–484 (2009).• Addresses how host genotype, environmental exposure and host adiposity influence the gut microbiome.
  Medline CASGoogle Scholar
• 44  Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature444(7122),1027–1031 (2006).
  MedlineGoogle Scholar
• 45  Bergheim I, Weber S, Vos M et al.: Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol.48(6),983–992 (2008).
  Medline CASGoogle Scholar
• 46  Kelley GL, Allan G, Azhar S: High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology145(2),548–555 (2004).
  Medline CASGoogle Scholar
• 47  Vos M, McClain CJ, Jones D: Fructose is associated with increased oxidative stress and elevated plasma triglycerides in children with nonalcoholic fatty liver disease. Hepatology48(S1),820A (2008).
  Google Scholar
• 48  Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE: Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics115(5),e561–e565 (2005).
  MedlineGoogle Scholar
• 49  Louthan MV, Theriot JA, Zimmerman E, Stutts JT, McClain CJ: Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J. Pediatr. Gastroenterol. Nutr.41(4),426–429 (2005).
  MedlineGoogle Scholar
• 50  Schwimmer JB, Celedon MA, Lavine JE et al.: Heritability of nonalcoholic fatty liver disease. Gastroenterology136,1585–1592 (2009)•• Establishes the genetic contribution to fatty liver disease.
  MedlineGoogle Scholar
• 51  Gawrieh S, Wallace J, Carless M et al.: Discovery of gene networks involved in non-alcoholic fatty liver disease using genome-wide transcriptional profiling. Hepatology48(S1),811A (2008).
  Google Scholar
• 52  National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation106(25),3143–3421 (2002).
  MedlineGoogle Scholar
• 53  Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S: Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation118(3),277–283 (2008).•• Demonstrates a strong association between NAFLD and multiple cardiovascular risk factors in obese children with biopsy-proven NAFLD.
  Medline CASGoogle Scholar
• 54  Mori K, Emoto M, Yokoyama H et al.: Association of serum fetuin-A with insulin resistance in Type 2 diabetic and nondiabetic subjects. Diabetes Care.29(2),468 (2006).
  MedlineGoogle Scholar
• 55  Reinehr T, Roth CL: Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J. Clin. Endocrinol. Metab.93(11),4479–4485 (2008).
  Medline CASGoogle Scholar
• 56  Shulman GI: Cellular mechanisms of insulin resistance. J. Clin. Invest.106(2),171–176 (2000).
  Medline CASGoogle Scholar
• 57  Ekstedt M, Franzen LE, Mathiesen UL et al.: Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology44(4),865–873 (2006).
  Medline CASGoogle Scholar
• 58  Nadeau KJ, Klingensmith G, Zeitler P: Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J. Pediatr. Gastroenterol. Nutr.41(1),94–98 (2005).
  Medline CASGoogle Scholar
• 59  Targher G, Bertolini L, Padovani R et al.: Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care.29(6),1325–1330 (2006).
  MedlineGoogle Scholar
• 60  Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G: Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care.27(10),2498–2500 (2004).
  MedlineGoogle Scholar
• 61  Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E: Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case–control study. Arterioscler. Thromb. Vasc. Biol.25(5),1045–1050 (2005).
  Medline CASGoogle Scholar
• 62  Volzke H, Robinson DM, Kleine V et al.: Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J. Gastroenterol.11(12),1848–1853 (2005).
  MedlineGoogle Scholar
• 63  Ioannou GN, Weiss NS, Boyko EJ, Mozaffarian D, Lee SP: Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology43(5),1145–1151 (2006).
  Medline CASGoogle Scholar
• 64  Villanova N, Moscatiello S, Ramilli S et al.: Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology42(2),473–480 (2005).
  MedlineGoogle Scholar
• 65  Shiotani A, Motoyama M, Matsuda T, Miyanishi T: Brachial-ankle pulse wave velocity in Japanese university students. Intern. Med.44(7),696–701 (2005).
  MedlineGoogle Scholar
• 66  Pacifico L, Cantisani V, Ricci P et al.: Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr. Res.63(4),423–427 (2008).•• Demonstrates an association between NAFLD and carotid atherosclerosis in children.
  Medline CASGoogle Scholar
• 67  Monzavi R, Dreimane D, Geffner ME et al.: Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle intervention. Pediatrics117(6),e1111–e1118 (2006).
  MedlineGoogle Scholar
• 68  Nobili V, Manco M, Devito R et al.: Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology48(1),119–128 (2008).• First study to show improvement in liver histology in children afterlifestyle intervention.
  Medline CASGoogle Scholar
• 69  Nobili V, Marcellini M, Devito R et al.: NAFLD in children: a prospective clinical–pathological study and effect of lifestyle advice. Hepatology44(2),458–465 (2006).
  MedlineGoogle Scholar
• 70  Schwimmer JB, Middleton MS, Deutsch R, Lavine JE: A Phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther.21(7),871–879 (2005).
  Medline CASGoogle Scholar
• 71  Nobili V, Manco M, Ciampalini P et al.: Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin. Ther.30(6),1168–1176 (2008).
  Medline CASGoogle Scholar
• 72  Lavine JE, Schwimmer JB: Clinical Research Network launches TONIC trial for treatment of nonalcoholic fatty liver disease in children. J. Pediatr. Gastroenterol. Nutr.42(2),129–130 (2006).
  MedlineGoogle Scholar